Nuzenio

Keensight Capital

Keensight Capital news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in HealthcareInvestors in Healthcare · Thu, 06 Aug 2026 11:38:51 GMTDC Advisory acts as the exclusive financial advisor to Halma plc on its sale of NovaBone Products to Isto Biologics, a portfolio company of Keensight Capital - DC AdvisoryDC Advisory · Wed, 05 Aug 2026 07:00:00 GMTIsto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This WeekOrthopedics This Week · Tue, 04 Aug 2026 22:22:22 GMT

Timeline

Thu, 06 Aug 2026 11:38:51 GMTUS: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Wed, 05 Aug 2026 07:00:00 GMTDC Advisory acts as the exclusive financial advisor to Halma plc on its sale of NovaBone Products to Isto Biologics, a portfolio company of Keensight Capital - DC Advisory
Tue, 04 Aug 2026 22:22:22 GMTIsto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Keensight Capital.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.